Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.

David A PalmaHanbo ChenHouda BahigStewart GaedeStephen HarrowJoanna M LabaX Melody QuGeorge B RodriguesBrian P YaremkoEdward YuAlexander V LouieInderdeep DhaliwalChristopher J Ryerson

Published in: BMC cancer (2019)

Clinicaltrials.gov identifier: NCT03485378. Date of registration: April 2, 2018.

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
open label
clinical trial
randomized controlled trial
placebo controlled
radiation therapy